Prevention of infection due to Pneumocystis carinii.
作者信息
Fishman J A
机构信息
Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
出版信息
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
Abstract
摘要
相似文献
1
Prevention of infection due to Pneumocystis carinii.预防卡氏肺孢子虫感染。
Antimicrob Agents Chemother. 1998 May;42(5):995-1004. doi: 10.1128/AAC.42.5.995.
2
[Therapy and prevention of pneumocystis carinii pneumonia].卡氏肺孢子虫肺炎的治疗与预防
Internist (Berl). 1995 Dec;36(12):1150-5.
3
Treatment of infection due to Pneumocystis carinii.卡氏肺孢子菌感染的治疗。
Antimicrob Agents Chemother. 1998 Jun;42(6):1309-14. doi: 10.1128/AAC.42.6.1309.
4
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.对人类免疫缺陷病毒（HIV）感染患者预防卡氏肺孢子虫肺炎和弓形虫性脑炎治疗方法的荟萃分析。
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 1;15(2):104-14. doi: 10.1097/00042560-199706010-00002.
5
Pneumocystis carinii pneumonia treatment in people infected with HIV.感染艾滋病毒者的卡氏肺孢子虫肺炎治疗
Clin Evid. 2004 Jun(11):935-50.
6
Treatment and prophylaxis of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎的治疗与预防
Semin Respir Infect. 1998 Dec;13(4):296-303.
7
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.获得性免疫缺陷综合征患者中卡氏肺孢子虫肺炎的管理选择及对甲氧苄啶/磺胺甲恶唑不耐受的情况。
South Med J. 1996 Mar;89(3):272-7. doi: 10.1097/00007611-199603000-00003.
8
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Lancet. 1991 May 11;337(8750):1162-3. doi: 10.1016/0140-6736(91)92829-q.
9
Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.在接受阿托伐醌预防卡氏肺孢子虫肺炎的患者中重新使用甲氧苄啶-磺胺甲恶唑。
Am J Health Syst Pharm. 2003 Aug 1;60(15):1572-4. doi: 10.1093/ajhp/60.15.1572.
10
Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎预防失败的原因。
AIDS. 1999 May 28;13(8):991-2. doi: 10.1097/00002030-199905280-00017.
引用本文的文献
1
Trends in the Epidemiology of Pneumonia in Immunocompromised Patients without HIV Infection.无HIV感染的免疫功能低下患者肺炎的流行病学趋势
J Fungi (Basel). 2023 Jul 31;9(8):812. doi: 10.3390/jof9080812.
2
Risk of Pneumonia among Solid Organ Transplant Recipients: A Population-Based Study.实体器官移植受者中肺炎的风险：一项基于人群的研究。
J Fungi (Basel). 2022 Dec 22;9(1):23. doi: 10.3390/jof9010023.
3
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review.炎症性肠病患者中预防卡氏肺孢子虫肺炎：系统评价。
Pharmacotherapy. 2022 Nov;42(11):858-867. doi: 10.1002/phar.2733. Epub 2022 Oct 25.
4
Comparison of early and late Pneumocystis jirovecii Pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) Study.肾移植患者中早发性和迟发性肺孢子菌肺炎的比较：韩国器官移植登记处（KOTRY）研究。
Sci Rep. 2022 Jun 23;12(1):10682. doi: 10.1038/s41598-022-14580-5.
5
Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review.肾移植受者移植13个月后发生肺炎：病例报告及文献综述
Acta Med Litu. 2021;28(1):136-144. doi: 10.15388/Amed.2020.28.1.5. Epub 2021 Jan 25.
6
Pneumonia in HIV-Positive and HIV-Negative Patients: A Single-Center Retrospective Study.HIV阳性和HIV阴性患者的肺炎：一项单中心回顾性研究。
Tanaffos. 2019 Mar;18(3):238-243.
7
Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.在当前常规移植后预防的时代，肾和胰肾联合移植受者中的卡氏肺孢子菌肺炎：危险因素和结局。
BMC Nephrol. 2018 Nov 21;19(1):332. doi: 10.1186/s12882-018-1142-8.
8
Pneumonia in Solid-Organ Transplant Recipients.实体器官移植受者的肺炎
J Fungi (Basel). 2015 Sep 28;1(3):293-331. doi: 10.3390/jof1030293.
9
Hypercalcaemia preceding diagnosis of pneumonia in renal transplant recipients.肾移植受者肺炎诊断前的高钙血症
Clin Kidney J. 2017 Dec;10(6):845-851. doi: 10.1093/ckj/sfx044. Epub 2017 Jun 23.
10
Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.从德国队列中获取的耶氏肺孢子菌菌株中二氢叶酸还原酶（DHFR）和二氢蝶酸合酶（DHPS）突变的低流行率
Infection. 2017 Jun;45(3):341-347. doi: 10.1007/s15010-017-1005-4. Epub 2017 Mar 16.
本文引用的文献
1
[Parasitic pneumonia. Interstitial plasma cell pneumonia of premature, caused by pneumocystis Carinii].[寄生虫性肺炎。早产儿间质性浆细胞肺炎，由卡氏肺孢子虫引起]
Zentralbl Bakteriol Orig. 1952 May 12;158(1-2):120-7.
2
Discovery of selective, small-molecule inhibitors of RNA complexes--II. Self-splicing group I intron ribozyme.RNA复合物选择性小分子抑制剂的发现——II. 自我剪接的I类内含子核酶
Bioorg Med Chem. 1997 Jun;5(6):1185-95. doi: 10.1016/s0968-0896(97)00065-5.
3
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.卡氏肺孢子虫中二氢蝶酸合酶多态性
J Infect Dis. 1997 Feb;175(2):482-5. doi: 10.1093/infdis/175.2.482.
4
Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia.对通过反复支气管肺泡灌洗从人类免疫缺陷病毒感染患者一次或多次肺炎发作期间分离出的人肺孢子菌的内转录间隔区和线粒体大亚基基因的研究。
J Clin Microbiol. 1997 Jul;35(7):1687-90. doi: 10.1128/jcm.35.7.1687-1690.1997.
5
Increased risk for opportunistic infections during chemotherapy in HIV-infected patients with Kaposi's sarcoma.
Dermatology. 1997;194(3):234-7. doi: 10.1159/000246109.
6
Penetration of dapsone into pulmonary lining fluid of human immunodeficiency virus type 1-infected patients.氨苯砜在1型人类免疫缺陷病毒感染患者肺内衬液中的渗透情况。
Antimicrob Agents Chemother. 1997 May;41(5):1077-81. doi: 10.1128/AAC.41.5.1077.
7
[Pneumocystis carinii pneumonia in patients with a solid organ transplant: a report of 5 cases].实体器官移植患者的卡氏肺孢子虫肺炎：5例报告
Rev Clin Esp. 1997 Jan;197(1):31-4.
8
Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.免疫抑制剂霉酚酸酯对卡氏肺孢子虫的新型抗虫效应，与他克莫司、西罗莫司和地塞米松的激发效应形成对比。
J Infect Dis. 1997 Apr;175(4):901-4. doi: 10.1086/513988.
9
[Infectious complications of lung and heart-lung transplantation].
Rev Mal Respir. 1996 Nov;13(5 Suppl):S41-7.
10
Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation--an open clinical trial.
Transplantation. 1996 Nov 27;62(10):1519-21. doi: 10.1097/00007890-199611270-00026.
Zotero 插件